-
Kenya's economy faces climate change risks: World Bank
-
Yoko says oh no to 'John Lemon' beer
-
Stocks sink amid fears over US-Iran ceasefire
-
Premier League losses soar for clubs locked in 'arms race'
-
For Israel's Circassians, food and language sustain an ancient heritage
-
'Super El Nino' raises fears for Asia reeling from Middle East conflict
-
Pulitzers honor damning coverage of Trump and his policies
-
US-Iran ceasefire on brink as UAE reports attacks
-
OpenAI co-founder under fire in Musk trial over $30 bn stake
-
Amazon to ship stuff for any business, not just its own merchants
-
Passengers stranded on cruise off Cape Verde following suspected virus deaths
-
What is hantavirus, and can it spread between humans?
-
Two dead as car ploughs into crowd in Germany's Leipzig
-
Demi Moore joins Cannes Festival jury
-
Two dead after car ploughs into people in Germany's Leipzig: mayor
-
Stars set for Met Gala, fashion's biggest night
-
France launches one-euro university meals for all students
-
Mysterious world beyond Pluto may have an atmosphere: astronomers
-
Energy crisis fuels calls to cut methane emissions
-
Hantavirus: spread by rodents, potentially fatal, with no specific cure
-
Musk vs OpenAI trial enters second week
-
Japan PM says oil crisis has 'enormous impact' in Asia-Pacific
-
Seoul, Taipei hit records as Asian stocks track Wall St tech rally
-
Boeing faces civil trial over 737 MAX crash
-
Pacific Avenue Capital Partners Enters into Exclusive Negotiations to Acquire ESE World, Amcor's European Waste Container Business
-
Three die on Atlantic cruise ship from suspected hantavirus: WHO
-
Two die in 'respiratory illness' outbreak on Atlantic cruise ship
-
More Nepalis drive electric, evading global fuel shocks
-
Latecomer Japan eyes slice of rising global defence spending
-
German fertiliser makers and farmers struggle with Iran war fallout
-
OPEC+ to make first post-UAE production decision
-
Massive crowds fill Rio's Copacabana beach for Shakira concert
-
US airlines step up as Spirit winds down
-
Aviation companies step up as Spirit winds down
-
'Bookless bookstore': audio-only book shop opens in New York
-
Venezuelan protesters call government wage hike a joke
-
S&P 500, Nasdaq end at fresh records on tech earnings strength
-
Pope names former undocumented migrant as US bishop of West Virginia
-
Trump says will raise US tariffs on EU cars to 25%
-
ExxonMobil CEO sees chance of higher oil prices as earnings dip
-
After Madonna and Lady Gaga, Shakira set for Rio beach mega-gig
-
King Charles gets warm welcome in Bermuda after whirlwind US visit
-
Coe hails IOC gender testing decision
-
Baguettes take centre stage on France's Labour Day
-
Iran offers new proposal amid stalled US peace talks
-
French hub monitors Hormuz tensions from afar
-
Oil steady after wild swing, stocks diverge in thin trading
-
Chinese swimmer Sun Yang reports cyberbullying to police
-
Iran activates air defences as Trump faces congressional deadline
-
India's cows offer biogas alternative to Mideast energy crunch
Morocco starts construction of anti-Covid vaccine plant
Morocco on Thursday inaugurated construction of an anti-Covid vaccine manufacturing plant in partnership with Swedish firm Recipharm, the official news agency MAP reported.
The factory to be known as Sensyo Pharmatech will produce vaccines against coronavirus and other diseases, with production expected to reach 116 million units in 2024, MAP said.
It was launched in Benslimane, a region of Morocco's economic hub Casablanca during a ceremony attended by King Mohammed VI, it said.
The plant will need investments of between 400-500 million euros ($445 million-$557 million).
It is aimed at ensuring vaccine "self-sufficiency" for the North African kingdom, MAP said.
Its goal is to make, between 2022 and 2025, "active substances for more than 20 vaccines, three of which would be against coronavirus... to cover 70 percent of the kingdom's needs and more than 60 percent of needs across Africa", the agency said.
Morocco is already producing the Chinese anti-Covid Sinopharm vaccine, with more than three million doses being made per month.
By next month it plans on producing five million doses and more than 20 million by the end of the year.
Home to 36 million inhabitants, Morocco is hoping that its vaccination drive will help eradicate Covid-19. More than 23 million people have already received a second dose against coronavirus, according to the health ministry.
Authorities hope to vaccinate 80 percent of the population with either Sinopharm or Pfizer-BioNTech.
In July, Recipharm said it had signed a memorandum of understanding with Morocco and a consortium of the country's leading banks to build a factory to produce vaccines and biotherapeutics in the kingdom.
As part of the deal, it said in a statement at the time, $500 million would be invested into the project by the Moroccan government and consortium.
"The investment is primarily to supply the African continent and help it gain vaccine sovereignty and access to future biotherapeutics," it said.
Y.Uduike--CPN